- Bio-Rad Levels Charges Against Zeiss
A dispute over rights to multiphoton fluorescence excitation has emerged between Carl Zeiss GmbH of Jena, Germany, and Bio-Rad Laboratories Inc. in Hertfordshire, UK.
Bio-Rad says it signed a worldwide exclusive license with Cornell University's research foundation in 1996 to commercialize and market the technology. Since then, it has worked with the Ithaca, N.Y., university to develop the technology.
MORE FROM PHOTONICS MEDIA